The influence of skeletal muscle on appetite regulation

References

• Buhmann H, le Roux CW, Bueter M. The gut–brain axis in obesity. Best Pract Res Clin Gastroenterol. 2014;28(4):559–571.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–781.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425.
   PubMed Web of Science ®Google Scholar
• Dulloo AG, Jacquet J, Miles-Chan JL, et al. Passive and active roles of fat-free mass in the control of energy intake and body composition regulation. Eur J Clin Nutr. 2017;71(3):353.
   PubMed Web of Science ®Google Scholar
• Morton GJ, Cummings DE, Baskin DG, et al. Central nervous system control of food intake and body weight. Nature. 2006;443(7109):289.
   PubMed Web of Science ®Google Scholar
• Sun Y, Butte NF, Garcia JM, et al. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology. 2007;149(2):843–850.
   PubMed Web of Science ®Google Scholar
• Ranganath LR, Beety JM, Morgan LM, et al. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut. 1996;38(6):916–919.
   PubMed Web of Science ®Google Scholar
• Le Roux CW, Patterson M, Vincent RP, et al. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab. 2005;90(2):1068–1071.
   PubMed Web of Science ®Google Scholar
• Riveros-McKay F, Mistry V, Bounds R, et al. Genetic architecture of human thinness compared to severe obesity. PLoS Genet. 2019;15(1):e1007603.
   PubMed Web of Science ®Google Scholar
• Silva FM, Giatti L, de Figueiredo RC, et al. Consumption of ultra-processed food and obesity: cross sectional results from the Brazilian longitudinal study of adult health (ELSA-Brasil) cohort (2008–2010). Public Health Nutr. 2018;21(12):2271–2279.
   PubMed Web of Science ®Google Scholar
• Gordon-Larsen P. Food availability/convenience and obesity. Adv Nutr. 2014;5(6):809–817.
   PubMed Web of Science ®Google Scholar
• Leigh SJ, Lee F, Morris MJ. Hyperpalatability and the generation of obesity: roles of environment, stress exposure and individual difference. Curr Obes Rep. 2018;7(1):6–18.
   PubMed Web of Science ®Google Scholar
• Rouhani MH, Haghighatdoost F, Surkan PJ, et al. Associations between dietary energy density and obesity: a systematic review and meta-analysis of observational studies. Nutrition. 2016;32(10):1037–1047.
   PubMed Web of Science ®Google Scholar
• Berthoud HR, Münzberg H, Morrison CD. Blaming the brain for obesity: integration of hedonic and homeostatic mechanisms. Gastroenterology. 2017;152(7):1728–1738.
   PubMed Web of Science ®Google Scholar
• Myers A, Gibbons C, Finlayson G, et al. Associations among sedentary and active behaviours, body fat and appetite dysregulation: investigating the myth of physical inactivity and obesity. Br J Sports Med. 2017;51(21):1540–1544.
   PubMed Web of Science ®Google Scholar
• Blundell JE, Caudwell P, Gibbons C, et al. Body composition and appetite: fat-free mass (but not fat mass or BMI) is positively associated with self-determined meal size and daily energy intake in humans. Br J Nutr. 2012;107(3):445–449.
   PubMed Web of Science ®Google Scholar
• Cameron JD, Sigal RJ, Kenny GP, et al. Body composition and energy intake—skeletal muscle mass is the strongest predictor of food intake in obese adolescents: the HEARTY trial. Appl Physiol Nutr Metab. 2016;41(6):611–617.
   PubMed Web of Science ®Google Scholar
• Blundell JE, Finlayson G, Gibbons C, et al. The biology of appetite control: do resting metabolic rate and fat-free mass drive energy intake? Physiol Behav. 2015;152:473–478.
   PubMed Web of Science ®Google Scholar
• Myers MG, Cowley MA, Münzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2018;70:537–556.
   Web of Science ®Google Scholar
• Weise CM, Hohenadel MG, Krakoff J, et al. Body composition and energy expenditure predict ad-libitum food and macronutrient intake in humans. Int J Obesity. 2014;38(2):243.
   PubMed Web of Science ®Google Scholar
• Ravussin E, Lillioja S, Knowler WC. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med. 1988;318(8):467–472.
   PubMed Web of Science ®Google Scholar
• Ravussin E, Lillioja S, Anderson TE, et al. Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest. 1986;78(6):1568–1578.
   PubMed Web of Science ®Google Scholar
• Elia M. Organ and tissue contribution to metabolic rate. In: Kinney JM, Tucker HN, editors.  Energy metabolism: tissue determinants and cellular corollaries. New York, NY: Raven Press; 1992p. 61–80.
   Google Scholar
• Hopkins M, Finlayson G, Duarte C, et al. Modelling the associations between fat-free mass, resting metabolic rate and energy intake in the context of total energy balance. Int J Obesity. 2016;40(2):312.
   Web of Science ®Google Scholar
• Piaggi P, Thearle MS, Krakoff J, et al. Higher daily energy expenditure and respiratory quotient, rather than fat-free mass, independently determine greater ad libitum overeating. J Clin Endocrinol Metab. 2015;100(8):3011–3020.
   PubMed Web of Science ®Google Scholar
• Hopkins M, Duarte C, Beaulieu K, et al. Activity energy expenditure is an independent predictor of energy intake in humans. Int J Obesity. 2019;1:1–9.
   Google Scholar
• Huynh MKQ, Kinyua AW, Yang DJ, et al. Hypothalamic AMPK as a regulator of energy homeostasis. Neural Plast. 2016.
   PubMed Web of Science ®Google Scholar
• Schwartz MW, Woods SC, Porte D Jr, et al. Central nervous system control of food intake. Nature. 2000;404(6778):661.
   PubMed Web of Science ®Google Scholar
• Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev. 2006;27(7):736–749.
   PubMed Web of Science ®Google Scholar
• López M, Nogueiras R, Tena-Sempere M, et al. Hypothalamic AMPK: a canonical regulator of whole-body energy balance. Nat Rev Endocrinol. 2016;12(7):421.
   PubMed Web of Science ®Google Scholar
• Claret M, Smith MA, Batterham RL, et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest. 2007;117(8):2325–2336.
   PubMed Web of Science ®Google Scholar
• Lim CT, Kola B, Korbonits M. AMPK as a mediator of hormonal signalling. J Mol Endocrinol. 2010;44(2):87–97.
   PubMed Web of Science ®Google Scholar
• Coope A, Milanski M, Araújo EP, et al. AdipoR1 mediates the anorexigenic and insulin/leptin‐like actions of adiponectin in the hypothalamus. FEBS Lett. 2008;582(10):1471–1476.
   PubMed Web of Science ®Google Scholar
• Lim CT, Kola B, Feltrin D, et al. Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism. Mol Cell Endocrinol. 2013;365(2):303–308.
   PubMed Web of Science ®Google Scholar
• Kola B, Hubina E, Tucci SA, et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem. 2005;280(26):25196–25201.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Kola B, Lolli F, et al. AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in cushing’s syndrome. Faseb J. 2008;22(6):1672–1683.
   PubMed Web of Science ®Google Scholar
• Di S, Malcher-Lopes R, Marcheselli VL, et al. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and γ-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology. 2005;146(10):4292–4301.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Arima H, Watanabe M, et al. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology. 2008;149(9):4544–4553.
   PubMed Web of Science ®Google Scholar
• Liu L, Song Z, Jiao H, et al. Glucocorticoids increase NPY gene expression via hypothalamic AMPK signaling in broiler chicks. Endocrinology. 2014;155(6):2190–2198.
   PubMed Web of Science ®Google Scholar
• Kim MS, Park JY, Namkoong C, et al. Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med. 2004;10(7):727.
   PubMed Web of Science ®Google Scholar
• Alquier T, Kawashima J, Tsuji Y, et al. Role of hypothalamic adenosine 5′-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology. 2007;148(3):1367–1375.
   PubMed Web of Science ®Google Scholar
• de Morentin PBM, González-García I, Martins L, et al. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab. 2014;20(1):41–53.
   PubMed Web of Science ®Google Scholar
• Tsai YC, Lee YM, Lam KK, et al. The role of hypothalamic AMP-activated protein kinase in ovariectomy-induced obesity in rats. Menopause. 2010;17(6):1194–1200.
   PubMed Web of Science ®Google Scholar
• Andersson U, Filipsson K, Abbott CR. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem. 2004;279(13):12005–12008.
   PubMed Web of Science ®Google Scholar
• Minokoshi Y, Alquier T, Furukawa N. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004;428(6982):569.
   PubMed Web of Science ®Google Scholar
• Hurtado-Carneiro V, Sanz C, Roncero I, et al. Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour. Mol Neurobiol. 2012;45(2):348–361.
   PubMed Web of Science ®Google Scholar
• Beiroa D, Imbernon M, Gallego R. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes. 2014;63(10):3346–3358.
   PubMed Web of Science ®Google Scholar
• Andersson U, Treebak JT, Nielsen JN. Exercise in rats does not alter hypothalamic AMP-activated protein kinase activity. Biochem Biophys Res Commun. 2005;329(2):719–725.
   PubMed Web of Science ®Google Scholar
• Steinbeck KS. The importance of physical activity in the prevention of overweight and obesity in childhood: a review and an opinion. Obesity Rev. 2001;2(2):117–130.
   PubMedGoogle Scholar
• Swift DL, McGee JE, Earnest CP, et al. The effects of exercise and physical activity on weight loss and maintenance. Prog Cardiovasc Dis. 2018;61:206–213.
   PubMed Web of Science ®Google Scholar
• Beaulieu K, Hopkins M, Blundell J, et al. Does habitual physical activity increase the sensitivity of the appetite control system? A systematic review. Sports Med. 2016;46(12):1897–1919.
   PubMed Web of Science ®Google Scholar
• Ruderman NB, Keller C, Richard AM, et al. Interleukin-6 regulation of AMP-activated protein kinase: potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes. 2006;55(Suppl. 2):S48–S54.
   PubMed Web of Science ®Google Scholar
• Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011;17(11):1481.
   PubMed Web of Science ®Google Scholar
• Wallenius V, Wallenius K, Ahrén B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med. 2002;8(1):75.
   PubMed Web of Science ®Google Scholar
• Hidalgo J, Florit S, Giralt M, et al. Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. Brain Behav Immun. 2010;24(1):119–126.
   PubMed Web of Science ®Google Scholar
• Timper K, Denson JL, Steculorum SM, et al. IL-6 improves energy and glucose homeostasis in obesity via enhanced central IL-6 trans-signaling. Cell Rep. 2017;19(2):267–280.
   PubMed Web of Science ®Google Scholar
• Matthews V, Åström MB, Chan MHS, et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia. 2009;52(7):1409–1418.
   PubMed Web of Science ®Google Scholar
• Takei N, Furukawa K, Hanyu O, et al. A possible link between BDNF and mTOR in control of food intake. Front Psychol. 2014;5:1093.
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463.
   PubMed Web of Science ®Google Scholar
• Anastasilakis AD, Polyzos SA, Saridakis ZG, et al. Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition. J Clin Endocrinol Metab. 2014;99(9):3247–3255.
   PubMed Web of Science ®Google Scholar
• Tekin S, Erden Y, Ozyalin F, et al. The effects of intracerebroventricular infusion of irisin on feeding behaviour in rats. Neurosci Lett. 2017;645:25–32.
   PubMed Web of Science ®Google Scholar
• Sundarrajan L, Unniappan S. Small interfering RNA mediated knockdown of irisin suppresses food intake and modulates appetite regulatory peptides in zebrafish. Gen Comp Endocrinol. 2017;252:200–208.
   PubMed Web of Science ®Google Scholar
• Martins C, Morgan LM, Bloom SR, et al. Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol. 2007;193(2):251–258.
   PubMed Web of Science ®Google Scholar
• Martins C, Kulseng B, King NA, et al. The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat. J Clin Endocrinol Metab. 2010;95(4):1609–1616.
   PubMed Web of Science ®Google Scholar
• Thorogood A, Mottillo S, Shimony A, et al. Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. Am J Med. 2011;124(8):747–755.
   PubMed Web of Science ®Google Scholar
• Gibbons C, Blundell JE, Caudwell P, et al. The role of episodic postprandial peptides in exercise-induced compensatory eating. J Clin Endocrinol Metab. 2017;102(11):4051–4059.
   PubMed Web of Science ®Google Scholar
• Islam H, Townsend LK, McKie GL, et al. Potential involvement of lactate and interleukin-6 in the appetite-regulatory hormonal response to an acute exercise bout. J Appl Physiol. 2017;123:614–623.
   PubMed Web of Science ®Google Scholar
• Warkentin LM, Das D, Majumdar SR, et al. The effect of weight loss on health‐related quality of life: systematic review and meta‐analysis of randomized trials. Obesity Rev. 2014;15(3):169–182.
   PubMed Web of Science ®Google Scholar
• Unick JL, Neiberg RH, Hogan PE, et al. Weight change in the first 2 months of a lifestyle intervention predicts weight changes 8 years later. Obesity. 2015;23(7):1353–1356.
   PubMed Web of Science ®Google Scholar
• Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001;21(1):323–341.
   PubMed Web of Science ®Google Scholar
• Wing RR, Phelan S. Long-term weight loss maintenance–. Am J Clin Nutr. 2005;82(1):222S–225S.
   PubMed Web of Science ®Google Scholar
• Fothergill E, Guo J, Howard L, et al. Persistent metabolic adaptation 6 years after “the biggest loser” competition. Obesity. 2016;24(8):1612–1619.
   PubMed Web of Science ®Google Scholar
• Dulloo AG, Jacquet J, Montani JP, et al. How dieting makes the lean fatter: from a perspective of body composition autoregulation through adipostats and proteinstats awaiting discovery. Obesity Rev. 2015;16:25–35.
   PubMed Web of Science ®Google Scholar
• Pietiläinen KH, Saarni SE, Kaprio J, et al. Does dieting make you fat? A twin study. Int J Obesity. 2012;36(3):456.
   Web of Science ®Google Scholar
• Dulloo AG, Jacquet J, Girardier L. Autoregulation of body composition during weight recovery in human: the minnesota experiment revisited. Int J Obes Relat Metab Disord. 1996;20(5):393–405.
   PubMed Web of Science ®Google Scholar
• Nindl BC, Friedl KE, Frykman PN, et al. Physical performance and metabolic recovery among lean, healthy men following a prolonged energy deficit. Int J Sports Med. 1997;18(05):317–324.
   PubMed Web of Science ®Google Scholar
• Friedl KE, Moore RJ, Hoyt RW, et al. Endocrine markers of semistarvation in healthy lean men in a multistressor environment. J Appl Physiol. 2000;88(5):1820–1830.
   PubMed Web of Science ®Google Scholar
• Vink RG, Roumans NJ, Arkenbosch LA, et al. The effect of rate of weight loss on long‐term weight regain in adults with overweight and obesity. Obesity. 2016;24(2):321–327.
   PubMed Web of Science ®Google Scholar
• Hao Z, Mumphrey MB, Townsend RL, et al. Reprogramming of defended body weight after R oux‐En‐Y gastric bypass surgery in diet‐induced obese mice. Obesity. 2016;24(3):654–660.
   PubMed Web of Science ®Google Scholar
• Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr. 2017;8(3):511–519.
   PubMed Web of Science ®Google Scholar
• Knuth ND, Johannsen DL, Tamboli RA, et al. Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity. 2014;22(12):2563–2569.
   PubMed Web of Science ®Google Scholar
• Li CJ, Yu Q, Yu P, et al. Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients. Cardiovasc Diabetol. 2014;13(1):36.
   PubMed Web of Science ®Google Scholar
• Chaston TB, Dixon JB, O’brien PE. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obesity. 2007;31(5):743.
   Web of Science ®Google Scholar
• Fisher FM, Maratos-Flier E. Understanding the physiology of FGF21. Annu Rev Physiol. 2016;78:223–241.
   PubMed Web of Science ®Google Scholar
• Solon-Biet SM, Cogger VC, Pulpitel T, et al. Defining the nutritional and metabolic context of FGF21 using the geometric framework. Cell Metab. 2016;24(4):555–565.
   PubMed Web of Science ®Google Scholar
• Sarruf DA, Thaler JP, Morton GJ, et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes. 2010;59(7):1817–1824.
   PubMed Web of Science ®Google Scholar
• Inagaki T, Lin VY, Goetz R, et al. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 2008;8(1):77–83.
   PubMed Web of Science ®Google Scholar
• Badman MK, Pissios P, Kennedy AR, et al. Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5(6):426–437.
   PubMed Web of Science ®Google Scholar
• Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627–1635.
   PubMed Web of Science ®Google Scholar
• Coskun T, Bina HA, Schneider MA, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149(12):6018–6027.
   PubMed Web of Science ®Google Scholar
• Xu J, Lloyd DJ, Hale C, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58(1):250–259.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yeung DC, Karpisek M, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57(5):1246–1253.
   PubMed Web of Science ®Google Scholar
• Díaz-Delfín J, Hondares E, Iglesias R, et al. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. Endocrinology. 2012;153(9):4238–4245.
   PubMed Web of Science ®Google Scholar
• Dushay JR, Toschi E, Mitten EK, et al. Fructose ingestion acutely stimulates circulating FGF21 levels in humans. Mol Metab. 2015;4(1):51–57.
   PubMed Web of Science ®Google Scholar
• Gaich G, Chien JY, Fu H, et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 2013;18(3):333–340.
   PubMed Web of Science ®Google Scholar
• Weigle DS, Breen PA, Matthys CC, et al. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations–. Am J Clin Nutr. 2005;82(1):41–48.
   PubMed Web of Science ®Google Scholar
• Larsen TM, Dalskov SM, van Baak M, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med. 2010;363(22):2102–2113.
   PubMed Web of Science ®Google Scholar
• Simpson SJ, Raubenheimer D. Obesity: the protein leverage hypothesis. Obesity Rev. 2005;6(2):133–142.
   PubMed Web of Science ®Google Scholar
• Austin GL, Ogden LG, Hill JO. Trends in carbohydrate, fat, and protein intakes and association with energy intake in normal-weight, overweight, and obese individuals: 1971–2006. Am J Clin Nutr. 2011;93(4):836–843.
   PubMed Web of Science ®Google Scholar
• Gosby AK, Conigrave AD, Raubenheimer D, et al. Protein leverage and energy intake. Obesity Rev. 2014;15(3):183–191.
   PubMed Web of Science ®Google Scholar
• Raubenheimer D, Zemke-White WL, Phillips RJ, et al. Algal macronutrients and food selection by the omnivorous marine fish Girella tricuspidata. Ecology. 2005;86(10):2601–2610.
   Web of Science ®Google Scholar
• Shariatmadari F, Forbes JM. Growth and food intake responses to diets of different protein contents and a choice between diets containing two concentrations of protein in broiler and layer strains of chicken. Br Poult Sci. 1993;34(5):959–970.
   PubMed Web of Science ®Google Scholar
• Raubenheimer D, Simpson SJ. Integrative models of nutrient balancing: application to insects and vertebrates. Nutr Res Rev. 1997;10(1):151–179.
   PubMed Web of Science ®Google Scholar
• Felton AM, Felton A, Raubenheimer D, et al. Protein content of diets dictates the daily energy intake of a free-ranging primate. Behav Ecol. 2009;20(4):685–690.
   Web of Science ®Google Scholar
• Sørensen A, Mayntz D, Raubenheimer D, et al. Protein‐leverage in mice: the geometry of macronutrient balancing and consequences for fat deposition. Obesity. 2008;16(3):566–571.
   PubMed Web of Science ®Google Scholar
• Gosby AK, Conigrave AD, Lau NS, et al. Testing protein leverage in lean humans: a randomised controlled experimental study. PLoS One. 2011;6(10):e25929.
   PubMed Web of Science ®Google Scholar
• Laeger T, Henagan TM, Albarado DC, et al. FGF21 is an endocrine signal of protein restriction. J Clin Invest. 2014;124(9):3913–3922.
   PubMed Web of Science ®Google Scholar
• Wek SA, Zhu S, Wek RC. The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids. Mol Cell Biol. 1995;15(8):4497–4506.
   PubMed Web of Science ®Google Scholar
• Laeger T, Albarado DC, Burke SJ, et al. Metabolic responses to dietary protein restriction require an increase in FGF21 that is delayed by the absence of GCN2. Cell Rep. 2016;16(3):707–716.
   PubMed Web of Science ®Google Scholar
• Kilberg MS, Balasubramanian M, Fu L, et al. The transcription factor network associated with the amino acid response in mammalian cells. Adv Nutr. 2012;3(3):295–306.
   PubMed Web of Science ®Google Scholar
• Gosby AK, Lau NS, Tam CS, et al. Raised FGF-21 and triglycerides accompany increased energy intake driven by protein leverage in lean, healthy individuals: a randomised trial. PLoS One. 2016;11(8):e0161003.
   PubMed Web of Science ®Google Scholar
• Recinella L, Leone S, Ferrante C, et al. Effects of central fibroblast growth factor 21 (FGF21) in energy balance. J Biol Regul Homeost Agents. 2017;31(3):603–613.
   PubMed Web of Science ®Google Scholar
• Longland TM, Oikawa SY, Mitchell CJ, et al. Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss: a randomized trial. Am J Clin Nutr. 2016;103(3):738–746.
   PubMed Web of Science ®Google Scholar
• McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member. Nature. 1997;387(6628):83.
   PubMed Web of Science ®Google Scholar
• McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Nat Acad Sci USA. 1997;94(23):12457–12461.
   PubMed Web of Science ®Google Scholar
• Kambadur R, Sharma M, Smith TP, et al. Mutations in myostatin (GDF8) in double-muscled Belgian blue and piedmontese cattle. Genome Res. 1997;7(9):910–915.
   PubMed Web of Science ®Google Scholar
• Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004;350(26):2682–2688.
   PubMed Web of Science ®Google Scholar
• Hittel DS, Axelson M, Sarna N, et al. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc. 2010;42(11):2023.
   PubMed Web of Science ®Google Scholar
• Ryan AS, Li G, Blumenthal JB, et al. Aerobic exercise+ weight loss decreases skeletal muscle myostatin expression and improves insulin sensitivity in older adults. Obesity. 2013;21(7):1350–1356.
   PubMed Web of Science ®Google Scholar
• McCroskery S, Thomas M, Maxwell L, et al. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol. 2003;162(6):1135–1147.
   PubMed Web of Science ®Google Scholar
• Lin J, Arnold HB, Della-Fera MA, et al. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun. 2002;291(3):701–706.
   PubMed Web of Science ®Google Scholar
• Yarasheski KE, Bhasin S, Sinha-Hikim I, et al. Serum myostatin-immunoreactive protein is increased in 60–92 year old women and men with muscle wasting. J Nutr Health Aging. 2002;6(5):343–348.
   PubMedGoogle Scholar
• Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Nat Acad Sci USA. 1998;95(25):14938–14943.
   PubMed Web of Science ®Google Scholar
• Reardon KA, Davis J, Kapsa RM, et al. Myostatin, insulin‐like growth factor‐1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve. 2001;24(7):893–899.
   PubMed Web of Science ®Google Scholar
• Hulmi JJ, Tannerstedt J, Selanne H, et al. Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men. J Appl Physiol. 2009;106(5):1720–1729.
   PubMed Web of Science ®Google Scholar
• Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004;20:61–86.
   PubMed Web of Science ®Google Scholar
• He Z, Zhang T, Jiang L, et al. Use of CRISPR/Cas9 technology efficiently targetted goat myostatin through zygotes microinjection resulting in double-muscled phenotype in goats. Biosci Rep. 2018;38(6):BSR20180742.
   PubMed Web of Science ®Google Scholar
• Allen DL, Cleary AS, Lindsay SF, et al. Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice. Am J Physiol Heart Circ Physiol. 2010;109(3):692–701.
   PubMed Web of Science ®Google Scholar
• Park JJ, Berggren JR, Hulver MW, et al. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics. 2006;27(2):114–121.
   PubMed Web of Science ®Google Scholar
• Milan G, Dalla Nora E, Pilon C, et al. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab. 2004;89(6):2724–2727.
   PubMed Web of Science ®Google Scholar
• Bužga M, Zavadilová V, Holéczy P, et al. Dietary intake and ghrelin and leptin changes after sleeve gastrectomy. Videosurgery Other Miniinvasive Tech. 2014;9(4):554.
   Web of Science ®Google Scholar
• Coutinho SR, Rehfeld JF, Holst JJ, et al. Impact of weight loss achieved through a multidisciplinary intervention on appetite in patients with severe obesity. Am J Physiol Endocrinol Metab. 2018;315:E91-E98.
   PubMed Web of Science ®Google Scholar
• Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–1604.
   PubMed Web of Science ®Google Scholar
• Nymo S, Coutinho SR, Jørgensen J, et al. Timeline of changes in appetite during weight loss with a ketogenic diet. Int J Obesity. 2017;41(8):1224.
   Web of Science ®Google Scholar
• Polidori D, Sanghvi A, Seeley RJ, et al. How strongly does appetite counter weight loss? Quantification of the feedback control of human energy intake. Obesity. 2016;24(11):2289–2295.
   PubMed Web of Science ®Google Scholar
• Nymo S, Coutinho SR, Eknes PH, et al. Investigation of the long-term sustainability of changes in appetite after weight loss. Int J Obesity. 2018;42:1489–1499.
   Web of Science ®Google Scholar
• Muller AF, Lamberts SW, Janssen JA, et al. Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol. 2002;146(2):203–207.
   PubMed Web of Science ®Google Scholar
• Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf). 2002;56(2):203–206.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Shannon MH. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab. 2003;88(7):2999–3002.
   PubMed Web of Science ®Google Scholar
• Yin X, Li Y, Xu G, et al. Ghrelin fluctuation, what determines its production? Acta Biochim Biophys Sin. 2009;41(3):188–197.
   Google Scholar
• Angeloni SV, Glynn N, Ambrosini G, et al. Characterization of the rhesus monkey ghrelin gene and factors influencing ghrelin gene expression and fasting plasma levels. Endocrinology. 2004;145(5):2197–2205.
   PubMed Web of Science ®Google Scholar
• Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87(6):2988–2991.
   PubMed Web of Science ®Google Scholar
• Ueberberg B, Unger N, Saeger W, et al. Expression of ghrelin and its receptor in human tissues. Hormone Metab Res. 2009;41(11):814–821.
   PubMed Web of Science ®Google Scholar
• Bertoli S, Magni P, Krogh V, et al. Is ghrelin a signal of decreased fat-free mass in elderly subjects? Eur J Endocrinol. 2006;155(2):321–330.
   PubMed Web of Science ®Google Scholar
• Tai K, Visvanathan R, Hammond AJ, et al. Fasting ghrelin is related to skeletal muscle mass in healthy adults. Eur J Nutr. 2009;48(3):176–183.
   PubMed Web of Science ®Google Scholar
• Jürimäe J, Cicchella A, Tillmann V, et al. Effect of pubertal development and physical activity on plasma ghrelin concentration in boys. J Endocrinol Invest. 2009;32(1):18–22.
   PubMed Web of Science ®Google Scholar
• Porporato PE, Filigheddu N, Reano S, et al. Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice. J Clin Invest. 2013;123(2):611–622.
   PubMed Web of Science ®Google Scholar
• Sheriff S, Kadeer N, Joshi R, et al. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Mol Cell Endocrinol. 2012;351(2):286–295.
   PubMed Web of Science ®Google Scholar
• Reano S, Angelino E, Ferrara M, et al. Unacylated ghrelin enhances satellite cell function and relieves the dystrophic phenotype in Duchenne muscular dystrophy mdx model. Stem Cells. 2017;35(7):1733–1746.
   PubMed Web of Science ®Google Scholar
• Angelino E, Reano S, Bollo A, et al. Ghrelin knockout mice display defective skeletal muscle regeneration and impaired satellite cell self-renewal. Endocrine. 2018;62(1):129–135.
   PubMed Web of Science ®Google Scholar
• Tamboli RA, Hajri T, Jiang A, et al. Reduction in inflammatory gene expression in skeletal muscle from Roux-en-Y gastric bypass patients randomized to omentectomy. PLoS One. 2011;6(12):e28577.
   PubMed Web of Science ®Google Scholar
• Chanoine JP. Ghrelin in growth and development. Hormone Res Paediatrics. 2005;63(3):129–138.
   Web of Science ®Google Scholar
• Lupu F, Terwilliger JD, Lee K, et al. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol. 2001;229(1):141–162.
   PubMed Web of Science ®Google Scholar
• Jorgensen JOL, Thuesen L, Ingemann-Hansen T, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1989;333(8649):1221–1225.
   Google Scholar
• Rommel C, Bodine SC, Clarke BA, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways. Nat Cell Biol. 2001;3(11):1009.
   PubMed Web of Science ®Google Scholar
• Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117(3):399–412.
   PubMed Web of Science ®Google Scholar
• EngströM BE, Burman P, Holdstock C, et al. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab. 2003;88(11):5193–5198.
   PubMed Web of Science ®Google Scholar
• Qi X, Reed J, Englander EW, et al. Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. Exp Biol Med. 2003;228(9):1028–1032.
   Web of Science ®Google Scholar
• Freda PU, Reyes CM, Conwell IM, et al. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J Clin Endocrinol Metab. 2003;88(5):2037–2044.
   PubMed Web of Science ®Google Scholar
• Bermann M, Jaffe CA, Tsai W, et al. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin. J Clin Invest. 1994;94(1):138–145.
   PubMed Web of Science ®Google Scholar
• Grinspoon S, Miller KK, Herzog DB, et al. Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. J Clin Endocrinol Metab. 2004;89(8):3988–3993.
   PubMed Web of Science ®Google Scholar
• Hengge UR, Stocks K, Faulkner S, et al. For the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women. HIV Clin Trials. 2003;4:150–163.
   PubMed Web of Science ®Google Scholar
• Demling RH, DeSanti L. The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent. Burns. 2001;27(1):46–51.
   PubMed Web of Science ®Google Scholar
• Mathews LS, Hammer RE, Brinster RL, et al. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology. 1998;123(1):433–437.
   Web of Science ®Google Scholar
• Bach MA, Shen-Orr Z, Lowe WL Jr, et al. Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain. Mol Brain Res. 1991;10(1):43–48.
   PubMedGoogle Scholar
• Hong H, Cui ZZ, Zhu L, et al. Central IGF1 improves glucose tolerance and insulin sensitivity in mice. Nutr Diabetes. 2017;7(12):2.
   PubMed Web of Science ®Google Scholar
• Pasarica M, Zachwieja JJ, DeJonge L, et al. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity. J Clin Endocrinol Metab. 2007;92(11):4265–4270.
   PubMed Web of Science ®Google Scholar
• Yackobovitch-Gavan M, Gat-Yablonski G, Shtaif B, et al. Growth hormone therapy in children with idiopathic short stature–the effect on appetite and appetite-regulating hormones: a pilot study. Endocr Res. 2018;44(1-2):16–26.
   PubMed Web of Science ®Google Scholar
• Hart DW, Wolf SE, Chinkes DL, et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg. 2000;232(4):455.
   PubMed Web of Science ®Google Scholar
• Herndon DN, Ramzy PI, DebRoy MA, et al. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg. 1999;229(5):713.
   PubMed Web of Science ®Google Scholar
• Pereira C, Murphy K, Jeschke M, et al. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol. 2005;37(10):1948–1961.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam A, Joshi R, Su C, et al. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases, MuRF1 and MAFbx. Am J Physiol Regul Integr Comp Physiol. 2009;296:R893-R901.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam A, Wood S, Joshi R, et al. Ghrelin stimulates food intake and growth hormone release in rats with thermal injury: synthesis of ghrelin. Peptides. 2006;27(7):1624–1631.
   PubMed Web of Science ®Google Scholar
• Costelli P, Muscaritoli M, Bossola M, et al. IGF-1 is down-regulated in experimental cancer cachexia. Am J Physiol Regul Integr Comp Physiol. 2006;291:R674-R683.
   PubMed Web of Science ®Google Scholar
• Schmidt K, von Haehling S, Doehner W, et al. IGF‐1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle. 2011;2(2):105–109.
   PubMed Web of Science ®Google Scholar
• Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 2001;104(17):2034–2038.
   PubMed Web of Science ®Google Scholar
• DeBoer MD, Zhu XX, Levasseur P, et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 2007;148(6):3004–3012.
   PubMed Web of Science ®Google Scholar
• Palus S, Schur R, Akashi YJ, et al. Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model. PLoS One. 2011;6(11):e26865.
   PubMed Web of Science ®Google Scholar
• Sugiyama M, Yamaki A, Furuya M, et al. Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice. Regul Pept. 2012;178(1–3):21–28.
   PubMed Web of Science ®Google Scholar
• Savastano S, Di Somma C, Angrisani L, et al. Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study. J Clin Endocrinol Metab. 2009;94(3):817–826.
   PubMed Web of Science ®Google Scholar
• Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Kocełak P, et al. The effect of weight reduction on plasma concentrations of ghrelin and insulin-like growth factor 1 in obese women. Endokrynol Pol. 2008;59(4):301–304.
   PubMedGoogle Scholar
• Galli G, Pinchera A, Piaggi P, et al. Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding. Obes Surg. 2012;22(8):1276–1280.
   PubMed Web of Science ®Google Scholar
• Pardina E, Ferrer R, Baena-Fustegueras JA, et al. The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obes Surg. 2010;20(5):623–632.
   PubMed Web of Science ®Google Scholar
• Rasmussen MH, Juul A, Hilsted J. Effect of weight loss on free insulin‐like growth factor‐i in obese women with hyposomatotropism. obesity. 2007;15(4):879–886.
   PubMed Web of Science ®Google Scholar
• Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc. 2001;60(1):91–106.
   PubMed Web of Science ®Google Scholar
• Lien LF, Haqq AM, Arlotto M, et al. The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain. Omics. 2009;13(1):21–35.
   PubMed Web of Science ®Google Scholar
• EngströM BE, Burman P, Holdstock C, et al. Effects of gastric bypass on the GH/IGF-I axis in severe obesity–and a comparison with GH deficiency. Eur J Endocrinol. 2006;154(1):53–59.
   PubMed Web of Science ®Google Scholar
• Mason C, Xiao L, Duggan C, et al. Effects of dietary weight loss and exercise on insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in postmenopausal women: a randomized controlled trial. Cancer Epidemiol Prev Biomarkers. 2013;22(8):1457–1463.
   PubMed Web of Science ®Google Scholar
• Lenk K, Erbs S, Höllriegel R, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol. 2012;19(3):404–411.
   PubMed Web of Science ®Google Scholar
• Williams NG, Interlichia JP, Jackson MF, et al. Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis. Endocrinology. 2011;152(1):172–180.
   PubMed Web of Science ®Google Scholar
• Oppert JM, Bellicha A, Roda C, et al. Resistance training and protein supplementation increase strength after bariatric surgery: a randomized controlled trial. Obesity. 2018;26(11):1709–1720.
   PubMed Web of Science ®Google Scholar